NEWARK, N.J. & GREENVILLE, S.C.--(BUSINESS WIRE)--ARS Treatment Centers, a national leader in Office-Based Opioid Treatment (OBOT), announced today that it is continuing its expansion in New Jersey, opening new clinics in Newark and Galloway this week. The company now operates seven OBOT clinics in the state, all of which have opened in August and September as part of the company’s commitment to ensure that quality, local access to comprehensive treatment will no longer be a barrier to recovery for patients. The company has plans for additional expansion throughout the state over the next 12 months. In total, ARS operates more than 50 OBOT facilities in five states.
- The Newark clinic is located at 73-75 Ferry Street, (basement level), Newark, NJ 07105.
- The Galloway clinic is located at 337 E Jimmie Leeds Road, Suite A, Galloway, NJ 08205.
All ARS clinics see patients by appointment only. Patients seeking treatment services at any ARS facility should call (866)-866-9277 to schedule an appointment. ARS accepts Medicaid and most major commercial insurance plans.
“New Jersey, like many areas throughout the United States, is working hard to combat the growing opioid epidemic affecting our nation. The team at ARS is committed to providing critical, life-saving resources throughout the state in an effort to support the community leaders working to win this important fight,” said Dr. Kevin Moore, Director of Integrative Medicine at ARS Treatment Centers. “This week, with the addition of two new, strategically located OBOT clinics, we took an important step forward. The team at ARS will continue to support New Jersey with additional best-in-class addiction treatment resources.”
There are several job openings across the state of New Jersey for qualified medical professionals. Interested applicants can review open positions and apply HERE.
To learn more about ARS Treatment Centers resources, visit www.arstreatmentcenters.com.
About ARS Treatment Centers
ARS Treatment Centers is a subsidiary of Crossroad Treatment Centers. Headquartered in Greenville, SC, together the two brands operate more than 80 addiction treatment facilities in 10 states. With proven, individualized treatment plans (medication, counseling, and toxicology services) the family of dedicated doctors, nurse practitioners, counselors, and professionals at ARS and Crossroads are able to provide the highest quality of professional care to over 20,000 patients each month. Understanding that the opioid crisis is an epidemic that demands aggressive implementation of critical resources to increase patient access to treatment, ARS has committed to opening more than 20 new treatment facilities in the third and fourth quarter of 2019.
